HYPERPHOSPHATASAEMIA

This adverse event was reported 110 times

These drugs are most commonly taken by patients reporting HYPERPHOSPHATASAEMIA:

# Drug Count
0 AMLODIPINE 10
1 ESOMEPRAZOLE MAGNESIUM 9
2 CYCLOSPORINE 8
3 TACROLIMUS 8
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 8
5 TACROLIMUS OINTMENT 0.1% 8
6 MAGNESIUM OXIDE 7
7 DARUNAVIR 6
8 FUROSEMIDE 6
9 RITONAVIR 6
See all common drugs associated with HYPERPHOSPHATASAEMIA

HYPERPHOSPHATASAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOREMIFENE CITRATE 1 0.0023
1 MARAVIROC 4 0.0017
2 ADEFOVIR DIPIVOXIL 2 0.0016
3 PRALATREXATE 1 0.0015
4 RALTEGRAVIR 5 0.0010
5 PASIREOTIDE 2 0.0009
6 ETRAVIRINE 3 0.0007
7 CASPOFUNGIN ACETATE 1 0.0006
8 LANTHANUM CARBONATE 3 0.0006
9 PEGCETACOPLAN 1 0.0005
See all drugs enriched for association with HYPERPHOSPHATASAEMIA